Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI)
Identifying Genome Variants and Evaluating PRDM9 and piRNA Clusters as Candidates for Infertility in a Cohort of Individuals With Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI)
2 other identifiers
observational
500
1 country
2
Brief Summary
Background: Infertility affects 1 in 6 people. Often, the causes of infertility are unknown. Treatments are successful in only about 50% of cases. Infertility caused by non obstructive azoospermia in males and primary ovarian insufficiency in females can have genetic causes. Researchers want to learn more about these genes. Objective: To identify genes that may cause infertility. Eligibility: Adult men and women with non-obstructive azoospermia (NOA) or primary ovarian insufficiency (POI) of unknown cause. Design: Participants will provide a saliva sample. A kit will be sent to their home. The kit will contain a collection tube and a cotton swab. They will swirl the swab inside their mouth and then seal it in the tube. They will mail the tube back to the researchers. Male participants who are having a procedure done to collect tissue from their testes may opt to have leftover tissue provided to study researchers. This tissue would otherwise have been discarded. No new procedures will be performed just for this study. Data may be collected from participants medical records.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2026
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 21, 2026
CompletedFirst Posted
Study publicly available on registry
January 22, 2026
CompletedStudy Start
First participant enrolled
March 11, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2031
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2031
March 16, 2026
March 11, 2026
4.8 years
January 21, 2026
March 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Genetic associations with infertility (primary ovarian insufficiency, oligospermia, non obstructive azoospermia)
Across 5 years we will sequence patients with POI and NOA to determine genetic associations with infertility
5 years
Study Arms (3)
Non obstructive azoospermia
Men aged 18 and older who have no semen in the ejaculate with no evidence of pathologic transport of sperm
Oligospermia
Men aged 18 or older who have a concentration less than 5 million/mL in ejaculate with no other known cause of oligospermia.
Primary ovarian insufficiency
Women who have been diagnosed with primary ovarian insufficiency
Eligibility Criteria
Patients seeking infertility care diagnosed with primary ovarian insufficiency, non obstructive azoospermia, or oligospermia will be offered the opportunity to enroll in genetic sequencing to further evaluate genetic causes of infertility.
You may qualify if:
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Adult male or female, of reproductive age
- Clinical diagnosis of NOA, oligospermia, or POI.
- In good general health with no medical history suspected as the cause of infertility.
You may not qualify if:
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Current use of medications that may cause infertility (chemotherapy, etc.)
- Pregnant or lactating
- Medical history indicating known common cause of infertility such as karyotype anomalies, Y-chromosome microdeletions, known monogenic causes, or other medical history affecting gamete production (i.e. injuries, surgical operations, infections, radiation, or chemotherapy).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
National Institutes of Health Clinical Center (Remote and In-Person)
Bethesda, Maryland, 20892, United States
Shady Grove Fertility
Rockville, Maryland, 20850, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Todd S Macfarlan, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 21, 2026
First Posted
January 22, 2026
Study Start
March 11, 2026
Primary Completion (Estimated)
January 1, 2031
Study Completion (Estimated)
January 1, 2031
Last Updated
March 16, 2026
Record last verified: 2026-03-11
Data Sharing
- IPD Sharing
- Will not share